Trial Profile
Effects of antihypertensive treatment on cardiac remodelling and metabolic profile in HIV infected patients: Randomized longitudinal study with candesartan versus lercanidipine
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Candesartan cilexetil (Primary) ; Lercanidipine
- Indications Essential hypertension
- Focus Pharmacodynamics
- 24 Dec 2007 New trial record.